Vertex Pharmaceuticals has inched closer to bringing a new, non-opioid med to the blockbuster pain market, with the FDA accepting a rolling new drug application for the company’s NaV1.8 inhibitor ...
Vertex Pharmaceuticals has hit a snag in its efforts to follow up non-opioid pain reliever Journavx (suzetrigine). The Boston-based Big Biotech’s sodium channel inhibitor VX-993 failed to outpace ...
In her first full year at the top of cystic fibrosis juggernaut Vertex Pharmaceuticals, CEO Reshma Kewalramani has collected a pay package that rivals compensation at some Big Pharma companies.
One symbol located in the natal chart you should know about when studying astrology is called the Vertex. A Vertex is a controversial topic among astrologers generally considered a point of karmic or ...
Approval of Journavx for acute pain marks the first new class of acute pain medication approved by the FDA in over 20 years. The FDA has approved Vertex Pharmaceuticals’ Journavx (suzetrigine), a ...
WALTHAM, Mass. & BOSTON--(BUSINESS WIRE)--Skyhawk Therapeutics, Inc. and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today a strategic research collaboration and licensing agreement ...
Days before three scientists at Boston-based Vertex Pharmaceuticals will share a $3 million prize for revolutionizing the treatment of cystic fibrosis, the award — sometimes called the Oscars of ...
VANCOUVER, Sept. 26, 2012 /CNW/ - Northern Vertex Mining Corp. (TSX.V:NEE) (OTCQX:NHVCF) ("Northern Vertex") is pleased to announce plans to commence a resource definition drill program to expand the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback